Effective Pain Relief with Eleftha 375mg Injection

Eleftha 375mg Injection

Active constituent: Trastuzumab

Indications:

• Advanced and metastatic breast cancer (HER2 positive patients).
• Metastatic gastric cancer with increased levels of HER2 proteins.

Therapeutic effects:

• Selectively binds to HER2 proteins, stopping the growth of cancer cells.

Administration:

• Administered intravenously.
• First infusion for 90 minutes, subsequent infusions within 30 minutes if well tolerated.
• Use before or after surgery.

Safety advice:

• Pregnancy: discuss with your physician before taking. Not recommended during pregnancy unless advised by the doctor.
• Breastfeeding: avoid breastfeeding while on treatment and for at least 7 months after the final dose.
• Lungs: consult your doctor if you have any lung conditions before starting treatment.
• Liver: inform your physician of any liver disorders for dosage adjustment.
• Alcohol: consult your doctor to know if it is safe to consume alcohol while on treatment.
• Driving: avoid driving or handling machinery due to potential side effects like tiredness and dizziness.

Interaction with other drugs:

• Inform your doctor about all medications, including supplements and herbal products, before starting treatment.

Side effects:

• Serious: heart problems, allergic reactions, kidney problems, breathing difficulties.
• Common: fever, visual disturbances, nose bleeds or runny nose, hair loss, dizziness, nail disorders, weight loss, loss of appetite, bruising, dry mouth, liver inflammation, muscle pain, asthma/lung disorders.

Word of advice:

• Inform your doctor if you have a history of allergic reactions to Eleftha 375mg Injection.
• Avoid pregnancy and breastfeeding for at least 7 months after the last dose.
• Monitor heart parameters regularly during treatment.

FAQs:

1. Is Eleftha 375mg Injection used as a monotherapy in treating breast cancer? Eleftha 375mg Injection is generally given along with chemotherapy medications such as paclitaxel or docetaxel or platinum compounds. Sometimes, it is also given with hormonal agents for those patients with elevated hormonal status.

2. Does Eleftha 375mg Injection cause heart problems? Yes, Eleftha 375mg Injection can damage the heart muscles. Hence, it is advised to do heart check-ups every 3 months and continue till 2–5 years after the treatment completion.

3. Can I breastfeed while on treatment with Eleftha 375mg Injection? No, since the medicine tends to pass into breast milk, it is unsafe to breastfeed. Hence, it is advised not to breastfeed for a minimum of 7 months after the treatment with Eleftha 375mg Injection.

4. Can Eleftha 375mg Injection be consumed during pregnancy? No, it is unsafe to consume Eleftha 375mg Injection while you are pregnant. This medicine can cause harm to the baby by reducing the amount of amniotic fluid, the fluid surrounding the womb. It can also cause organ developmental issues such as poor lung development when consumed during pregnancy. If you are planning for pregnancy, it is advised to discuss the birth control methods as this medicine may impair your fertility.

Fact box:

• Molecule name: Trastuzumab
• Therapeutic class: Anti-cancer
• Pharmacological class: HER2 inhibitor

Tags: medical-injection, eleftha-drug, pain-relief-injection, anti-inflammatory, 375mg